vs
LifeStance Health Group, Inc.（LFST）与OMNICELL, INC.（OMCL）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是OMNICELL, INC.的1.2倍（$382.2M vs $309.9M），OMNICELL, INC.净利率更高（3.7% vs 3.1%，领先0.6%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 14.9%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $38.6M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 5.8%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
Omnicell是总部位于美国加州山景城的跨国医疗科技企业，专注于为医院及各类医疗机构提供药品管理自动化系统，同时面向零售药房推出用药依从性包装与患者互动软件，旗下产品使用Omnicell及EnlivenHealth两大品牌。
LFST vs OMCL — 直观对比
营收规模更大
LFST
是对方的1.2倍
$309.9M
营收增速更快
LFST
高出2.5%
14.9%
净利率更高
OMCL
高出0.6%
3.1%
自由现金流更多
LFST
多$8.0M
$38.6M
两年增速更快
LFST
近两年复合增速
5.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $309.9M |
| 净利润 | $11.7M | $11.4M |
| 毛利率 | — | 45.3% |
| 营业利润率 | 4.7% | 60.1% |
| 净利率 | 3.1% | 3.7% |
| 营收同比 | 17.4% | 14.9% |
| 净利润同比 | 264.1% | — |
| 每股收益（稀释后） | — | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTOMCL
| Q1 26 | — | $309.9M | ||
| Q4 25 | $382.2M | $314.0M | ||
| Q3 25 | $363.8M | $310.6M | ||
| Q2 25 | $345.3M | $290.6M | ||
| Q1 25 | $333.0M | $269.7M | ||
| Q4 24 | $325.5M | $306.9M | ||
| Q3 24 | $312.7M | $282.4M | ||
| Q2 24 | $312.3M | $276.8M |
净利润LFSTOMCL
| Q1 26 | — | $11.4M | ||
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.1M | $5.5M | ||
| Q2 25 | $-3.8M | $5.6M | ||
| Q1 25 | $709.0K | $-7.0M | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-6.0M | $8.6M | ||
| Q2 24 | $-23.3M | $3.7M |
毛利率LFSTOMCL
| Q1 26 | — | 45.3% | ||
| Q4 25 | — | 41.5% | ||
| Q3 25 | — | 43.3% | ||
| Q2 25 | — | 43.9% | ||
| Q1 25 | — | 41.1% | ||
| Q4 24 | — | 46.2% | ||
| Q3 24 | — | 43.3% | ||
| Q2 24 | — | 41.3% |
营业利润率LFSTOMCL
| Q1 26 | — | 60.1% | ||
| Q4 25 | 4.7% | 0.1% | ||
| Q3 25 | 2.0% | 2.7% | ||
| Q2 25 | -0.9% | 2.8% | ||
| Q1 25 | 0.5% | -4.3% | ||
| Q4 24 | 0.3% | 4.0% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | -5.1% | 1.2% |
净利率LFSTOMCL
| Q1 26 | — | 3.7% | ||
| Q4 25 | 3.1% | — | ||
| Q3 25 | 0.3% | 1.8% | ||
| Q2 25 | -1.1% | 1.9% | ||
| Q1 25 | 0.2% | -2.6% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -1.9% | 3.1% | ||
| Q2 24 | -7.5% | 1.3% |
每股收益（稀释后）LFSTOMCL
| Q1 26 | — | $0.25 | ||
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | — | $0.19 | ||
| Q2 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $239.2M |
| 总债务越低越好 | $282.8M | — |
| 股东权益账面价值 | $1.5B | $1.3B |
| 总资产 | $2.2B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTOMCL
| Q1 26 | — | $239.2M | ||
| Q4 25 | $248.6M | $196.5M | ||
| Q3 25 | $203.9M | $180.1M | ||
| Q2 25 | $188.9M | $399.0M | ||
| Q1 25 | $134.3M | $386.8M | ||
| Q4 24 | $154.6M | $369.2M | ||
| Q3 24 | $102.6M | $570.6M | ||
| Q2 24 | $87.0M | $556.8M |
总债务LFSTOMCL
| Q1 26 | — | — | ||
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — |
股东权益LFSTOMCL
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $1.2B |
总资产LFSTOMCL
| Q1 26 | — | $2.0B | ||
| Q4 25 | $2.2B | $2.0B | ||
| Q3 25 | $2.1B | $1.9B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.1B | $2.2B | ||
| Q4 24 | $2.1B | $2.1B | ||
| Q3 24 | $2.1B | $2.3B | ||
| Q2 24 | $2.1B | $2.3B |
负债/权益比LFSTOMCL
| Q1 26 | — | — | ||
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $54.5M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | $38.6M |
| 自由现金流率自由现金流/营收 | 12.2% | 12.5% |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 4.93× | 4.80× |
| 过去12个月自由现金流最近4个季度 | $110.0M | $110.8M |
8季度趋势，按日历期对齐
经营现金流LFSTOMCL
| Q1 26 | — | $54.5M | ||
| Q4 25 | $57.6M | $30.4M | ||
| Q3 25 | $27.3M | $28.3M | ||
| Q2 25 | $64.4M | $42.8M | ||
| Q1 25 | $-3.1M | $25.9M | ||
| Q4 24 | $62.3M | $56.3M | ||
| Q3 24 | $22.7M | $22.8M | ||
| Q2 24 | $44.1M | $58.7M |
自由现金流LFSTOMCL
| Q1 26 | — | $38.6M | ||
| Q4 25 | $46.6M | $22.6M | ||
| Q3 25 | $17.0M | $18.5M | ||
| Q2 25 | $56.6M | $31.0M | ||
| Q1 25 | $-10.3M | $14.8M | ||
| Q4 24 | $56.0M | $47.2M | ||
| Q3 24 | $17.7M | $13.9M | ||
| Q2 24 | $39.0M | $49.1M |
自由现金流率LFSTOMCL
| Q1 26 | — | 12.5% | ||
| Q4 25 | 12.2% | 7.2% | ||
| Q3 25 | 4.7% | 6.0% | ||
| Q2 25 | 16.4% | 10.7% | ||
| Q1 25 | -3.1% | 5.5% | ||
| Q4 24 | 17.2% | 15.4% | ||
| Q3 24 | 5.7% | 4.9% | ||
| Q2 24 | 12.5% | 17.8% |
资本支出强度LFSTOMCL
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 2.5% | ||
| Q3 25 | 2.8% | 3.1% | ||
| Q2 25 | 2.2% | 4.1% | ||
| Q1 25 | 2.2% | 4.1% | ||
| Q4 24 | 1.9% | 3.0% | ||
| Q3 24 | 1.6% | 3.1% | ||
| Q2 24 | 1.6% | 3.5% |
现金转化率LFSTOMCL
| Q1 26 | — | 4.80× | ||
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | 5.18× | ||
| Q2 25 | — | 7.58× | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | — | 15.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
OMCL
| Product revenues | $174.8M | 56% |
| Service revenues | $135.1M | 44% |
